This map shows the geographic impact of L Lauerová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Lauerová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Lauerová more than expected).
This network shows the impact of papers produced by L Lauerová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Lauerová. The network helps show where L Lauerová may publish in the future.
Co-authorship network of co-authors of L Lauerová
This figure shows the co-authorship network connecting the top 25 collaborators of L Lauerová.
A scholar is included among the top collaborators of L Lauerová based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with L Lauerová. L Lauerová is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Slabý, Ondřej, et al.. (2009). Expression pattern of HLA class I antigens in renal cell carcinoma and primary cell line cultures: methodological implications for immunotherapy.. PubMed. 15(12). CR638–43.20 indexed citations
Lauerová, L, et al.. (2002). Malignant melanoma associates with Th1/Th2 imbalance that coincides with disease progression and immunotherapy response.. PubMed. 49(3). 159–66.80 indexed citations
8.
Žaloudík, Jan, et al.. (1999). Significance of pre-treatment immunological parameters in colorectal cancer patients with unresectable metastases to the liver.. PubMed. 46(25). 220–7.19 indexed citations
9.
Lauerová, L, Ladislav Dušek, Pavel Šlampa, et al.. (1999). Renal cell carcinoma-associated immune impairment that may interfere with the response to cytokine therapy.. PubMed. 46(3). 141–9.8 indexed citations
10.
Vojtěšek, Bořivoj, Jan Kovařík, Rudolf Nenutil, et al.. (1995). p53 protein overexpression associates with growth patterns rather than with metastasizing in operable breast cancer.. PubMed. 42(6). 331–6.
11.
Vojtěšek, Bořivoj, Hana Doležalová, L Lauerová, et al.. (1995). Conformational changes in p53 analysed using new antibodies to the core DNA binding domain of the protein.. PubMed. 10(2). 389–93.67 indexed citations
Lauerová, L, et al.. (1992). Fusion-induced malignancy? A preliminary study. (a challenge to today's common wisdom).. PubMed. 39(2). 79–86.8 indexed citations
Bártek, Jiří, et al.. (1985). Monoclonal antibody to intermediate filaments of cytokeratin type. I. Drug studies and reactivity with cultured cells and tissue sections.. PubMed. 31(1). 1–8.2 indexed citations
16.
Kovařík, Jan, et al.. (1983). Leukocyte adherence inhibition responses obtained with various tumor extracts in breast cancer patients.. PubMed. 6(1-2). 215–9.
17.
Kovařík, Josef, et al.. (1983). DNCB and PPD skin testing in breast cancer.. PubMed. 30(4). 385–9.1 indexed citations
18.
Lauerová, L, et al.. (1980). Humoral and cellular immunity in long-term surviving patients with malignant lymphoma.. PubMed. 27(3). 301–6.4 indexed citations
Kovařík, Jan, et al.. (1978). Establishment of cell line derived from human malignant melanoma.. PubMed. 25(6). 701–12.2 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.